share_log

AEON Biopharma | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Director PALMISANO ROBERT J

SEC ·  Sep 11, 2024 03:08
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more